
The webinar describes how human cells, tissues, or cellular and tissue-based products (HCT/Ps) are regulated under 21 CFR 1271. It discusses the origins of Good Tissue Practices (GTPs), the challenges in industrial cell therapy product development, the academic context of cell therapies, and the misconceptions and pitfalls in HCT/P classification. The webinar also includes an explanation of donor eligibility and safety considerations in HCT/Ps.
Register for additional free live webinars and available webinar replays.